Changes of serum cytokines after the long term immunotherapy with Japanese hop pollen extracts

Journal of Korean Medical Science

Volumn 21, Issue 5, 2006, Pages 805-810

  Ye, Young Min ^a   Lee, Soo Keol ^b   Kim, Seung Hyun ^a   Nahm, Dong Ho ^a   Suh, Chang Hee ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

^b Dong A University   (South Korea)

Author keywords

Allergen immunotherapy; Desensitization, immunologic; Interleukin 10; Pollen; Specific IgG; Transforming growth factor beta 1

Indexed keywords

EID: 33750224509     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.5.805     Document Type: Article

References (18)

1. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic disease: J Allergy Clin Immunol 1998; 102: 558-62.
2. Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol 2004; 113: 1013-23.
3. Jutel M, Akdis M, Budak F, Casaulta CA, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-14.
4. Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, Staple SQ, Aalberse RC, Till SJ, Durham SR. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172: 3252-9.
5. Park HS, Nahm DH, Suh CH, Lee SM, Choi SY, Jung KS, Lee SY, Park K. Evidence of Hop Japanese pollinosis in Korea: IgE sensitization and identification of allergenic components. J Allergy Clin Immunol 1997; 100: 475-9.
6. Park HS, Nahm DH, Kim HY, Suh YJ, Cho JW, Kim SS, Lee SK, Jung KS. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen. Ann Allergy Asthma Immunol 2001; 86: 444-8.
7. Bonifazi F, Bilo MB. Efficacy of specific immunotherapy in allergic asthma: myth or reality? Allergy 1997; 52: 698-710.
8. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.
9. Taicopoulos A, Joseph M. The role of CD23 in allergic disease. Clin Exp Allergy 2000; 30: 602-5.
10. Tanaka A, Ohashi Y, Nakai Y. Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis. Ann Otol Rhinol Laryngol 1999; 108: 193-200.
11. Boznanski A, Willak JE, Domanasiewicz M, Pirogowicz I, Widerska A. Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy. Pneumonol Alergol Pol 1996; 64: 386-91.
12. Van Neerven RJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Würtzen PA. A double blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 2004; 34: 420-8.
13. Jenmalm MC, Björkstén B, Macaubas C, Holt BJ, Smallacombe TB, Holt PG. Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobulin E and immunoglobulin G subclass antibody responses. Pediatr Allergy Immunol 1999; 10: 168-77.
14. Malling HJ. Allergen-specific immunotherapy: present state and directions for the future. Allergy 1999; 54: 30-3.
15. Wilcock LK, Francis JN, Durham SR. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy 2004; 34: 1373-8.
16. Punneonen JR, Waal MR, Van VP, Gauchat JF, Vries JE. IL-10 and viral IL-10 prevent IL-4 induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993; 151: 1280-9.
17. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. The role of IL-10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
18. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003; 112: 915-22.